{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:10:46Z","timestamp":1793387446581,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ygyno.2016.05.014","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T10:05:44Z","timestamp":1464516344000},"page":"574-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Prognostic implications of reproductive and lifestyle factors in ovarian cancer"],"prefix":"10.1016","volume":"142","author":[{"given":"Elizabeth M.","family":"Poole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis A.","family":"Konstantinopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.05.014_bb0005","series-title":"Cancer Incidence and Mortality Worldwide","article-title":"GLOBOCAN 2012 v1.0","volume":"No. 11","author":"Ferlay","year":"2013"},{"key":"10.1016\/j.ygyno.2016.05.014_bb0010","series-title":"Cancer Facts & Figures 2016","author":"American Cancer Society","year":"2016"},{"issue":"24","key":"10.1016\/j.ygyno.2016.05.014_bb0015","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.014_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.ygyno.2016.05.014_bb0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1200\/JCO.2003.03.039","article-title":"Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/AOG.0000000000000981","article-title":"Characteristics of long-term survivors of epithelial ovarian cancer","volume":"126","author":"Cress","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2016.05.014_bb0035","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/bjc.2014.29","article-title":"Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis","volume":"110","author":"Kim","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2016.05.014_bb0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ncponc1178","article-title":"Gene-expression profiling in epithelial ovarian cancer","volume":"5","author":"Konstantinopoulos","year":"2008","journal-title":"Nat Clin Pract Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2016.05.014_bb0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2016.05.014_bb0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer","volume":"36","author":"Prat","year":"2005","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.014_bb0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"issue":"34","key":"10.1016\/j.ygyno.2016.05.014_bb0060","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1200\/JCO.2008.16.1703","article-title":"\u201cBRCAness\u201d syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations","volume":"26","author":"Tan","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jnci\/djs494","article-title":"Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2","volume":"105","author":"McLaughlin","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1158\/1078-0432.CCR-14-2497","article-title":"For E, kConFab I, Australian Ovarian Cancer Study G. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer","volume":"21","author":"Candido-dos-Reis","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2016.05.014_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","author":"M\u00f8ller","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2009.068130","article-title":"Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds","volume":"47","author":"Grindedal","year":"2010","journal-title":"J. Med. Genet."},{"issue":"21","key":"10.1016\/j.ygyno.2016.05.014_bb0090","first-page":"4881","article-title":"The role of DNA mismatch repair in platinum drug resistance","volume":"56","author":"Fink","year":"1996","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.ygyno.2016.05.014_bb0095","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/1055-9965.EPI-15-0240","article-title":"Investigation of exomic variants associated with overall survival in ovarian cancer","volume":"25","author":"Winham","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2016.05.014_bb0105","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1158\/1078-0432.CCR-15-0632","article-title":"Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium","volume":"21","author":"Johnatty","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"2 Suppl","key":"10.1016\/j.ygyno.2016.05.014_bb0110","first-page":"606","article-title":"Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience","volume":"71","author":"Thigpen","year":"1993","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2016.05.014_bb0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/djt065","article-title":"Disparities in ovarian cancer care quality and survival according to race and socioeconomic status","volume":"105","author":"Bristow","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.05.014_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fpubh.2015.00008","article-title":"The effect of neighborhood disadvantage on the racial disparity in ovarian cancer-specific survival in a large hospital-based study in cook county, illinois","volume":"3","author":"Peterson","year":"2015","journal-title":"Front. Public Health"},{"issue":"8","key":"10.1016\/j.ygyno.2016.05.014_bb0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.annepidem.2015.03.021","article-title":"The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois","volume":"25","author":"Brewer","year":"2015","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.014_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.11.025","article-title":"Have racial disparities in ovarian cancer increased over time? An analysis of SEER data","volume":"125","author":"Terplan","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.014_bb0135","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/AOG.0000000000000643","article-title":"Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines","volume":"125","author":"Bristow","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2014.10.009","article-title":"Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States","volume":"136","author":"Fuh","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.05.014_bb0145","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ijc.2910540605","article-title":"Reproductive factors and survival from ovarian cancer","volume":"54","author":"Jacobsen","year":"1993","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.014_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.99.4.505","article-title":"Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network","volume":"99","author":"Herman-Giddens","year":"1997","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1525-1438.2007.01031.x","article-title":"The influence of reproductive and hormonal factors on ovarian cancer survival","volume":"18","author":"Nagle","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2016.05.014_bb0160","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/bjc.2015.377","article-title":"Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study","volume":"113","author":"Besevic","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2016.05.014_bb0165","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/ijc.22218","article-title":"Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival","volume":"119","author":"Mascarenhas","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0170","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ijc.23429","article-title":"Predictors of ovarian cancer survival: a population-based prospective study in Sweden","volume":"123","author":"Yang","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.05.014_bb0175","doi-asserted-by":"crossref","DOI":"10.1159\/000442710","article-title":"Clinical and emergent biomarkers and their relationship to the prognosis of ovarian cancer","author":"Jatoi","year":"2016","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1158\/1055-9965.EPI-12-1183-T","article-title":"Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness","volume":"22","author":"Poole","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"5","key":"10.1016\/j.ygyno.2016.05.014_bb0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/1119-3077.158941","article-title":"The association between endometriosis and survival outcomes of ovarian cancer: evidence-based on a meta-analysis","volume":"18","author":"Yang","year":"2016","journal-title":"Niger. J. Clin. Pract."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajog.2013.05.032","article-title":"Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients","volume":"209","author":"Wang","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.014_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/gyno.1995.1271","article-title":"Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis","volume":"59","author":"McMeekin","year":"1995","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0200","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/modpathol.2011.161","article-title":"Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma","volume":"25","author":"Katagiri","year":"2012","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/gyno.1998.5284","article-title":"Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation","volume":"72","author":"Komiyama","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2008.05.025","article-title":"Prognostic implication of endometriosis in clear cell carcinoma of the ovary","volume":"110","author":"Orezzoli","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2016.05.014_bb0215","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1158\/1055-9965.EPI-09-0156","article-title":"Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis","volume":"18","author":"Robbins","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.014_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1447-0756.2011.01683.x","article-title":"Tubal ligation and survival of ovarian cancer patients","volume":"38","author":"Zhang","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"35","key":"10.1016\/j.ygyno.2016.05.014_bb0230","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1200\/JCO.2015.60.9719","article-title":"Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial","volume":"33","author":"Eeles","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.014_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2014.01.030","article-title":"Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)","volume":"133","author":"Au-Yeung","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2016.05.014_bb0240","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jamaoncol.2015.1796","article-title":"Impact of chemotherapy dosing on ovarian cancer survival according to body mass index","volume":"1","author":"Bandera","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2016.05.014_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1757-2215-7-41","article-title":"Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis","volume":"7","author":"Bae","year":"2014","journal-title":"J. Ovarian Res."},{"issue":"5","key":"10.1016\/j.ygyno.2016.05.014_bb0250","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/01635580902825670","article-title":"Nutritional factors in ovarian cancer survival","volume":"61","author":"Bandera","year":"2009","journal-title":"Nutr. Cancer"},{"issue":"26","key":"10.1016\/j.ygyno.2016.05.014_bb0255","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2010.27.9752","article-title":"Weight, physical activity, diet, and prognosis in breast and gynecologic cancers","volume":"28","author":"McTiernan","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2016.05.014_bb0260","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1940-6207.CAPR-12-0048","article-title":"Obesity and ovarian cancer survival: a systematic review and meta-analysis","volume":"5","author":"Protani","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"5","key":"10.1016\/j.ygyno.2016.05.014_bb0265","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/bjc.2015.245","article-title":"Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium","volume":"113","author":"Nagle","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2010.10.035","article-title":"Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality","volume":"120","author":"Zhou","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2016.05.014_bb0275","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.11204","article-title":"Dietary influences on survival after ovarian cancer","volume":"106","author":"Nagle","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jada.2009.11.014","article-title":"Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer","volume":"110","author":"Dolecek","year":"2010","journal-title":"J. Am. Diet. Assoc."},{"issue":"11","key":"10.1016\/j.ygyno.2016.05.014_bb0285","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju314","article-title":"Diet quality and survival after ovarian cancer: results from the Women's Health Initiative","volume":"106","author":"Thomson","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0290","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2013.12.025","article-title":"Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival","volume":"132","author":"Dixon","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0295","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ijc.20456","article-title":"Green tea consumption enhances survival of epithelial ovarian cancer","volume":"112","author":"Zhang","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0300","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2015.03.016","article-title":"Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription","volume":"137","author":"Cannioto","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2016.05.014_bb0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.annepidem.2010.10.014","article-title":"Recreational physical activity and ovarian cancer risk and survival","volume":"21","author":"Moorman","year":"2011","journal-title":"Ann. Epidemiol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.05.014_bb0310","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/1055-9965.EPI-05-0897","article-title":"Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer","volume":"15","author":"Kjaerbye-Thygesen","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"12","key":"10.1016\/j.ygyno.2016.05.014_bb0315","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1158\/1055-9965.EPI-06-0592","article-title":"Cigarette smoking and survival after ovarian cancer diagnosis","volume":"15","author":"Nagle","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.ygyno.2016.05.014_bb0320","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ygyno.2015.11.008","article-title":"Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer","volume":"140","author":"Kelemen","year":"2016","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816307338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816307338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T01:04:22Z","timestamp":1567991062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816307338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0090825816307338"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.05.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic implications of reproductive and lifestyle factors in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}